Combination of glibenclamide–metformin HCl for the treatment of type 2 diabetes mellitus

Author： Lamos Elizabeth Mary   Stein Stephanie Aleskow   Davis Stephen N  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.13, Iss.17, 2012-12, pp. : 2545-2554

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tolerability Profile of Metformin/Glibenclamide Combination Tablets (Glucovance®): A New Treatment for the Management of Type 2 Diabetes Mellitus

By Jaime A. Davidson  

Drug Safety, Vol. 27, Iss. 15, 2004-01 ,pp. : 1205-1216

Adis International

Access to resources Recommend Favorite

Glibenclamide plus metformin combination tablets are effective, convenient and well tolerated in the treatment of type 2 diabetes mellitus

By Derosa Giuseppe  

Drugs & Therapy Perspectives, Vol. 22, Iss. 8, 2006-08 ,pp. : 1-6

Adis International

Access to resources Recommend Favorite

The French launch of the type 2 diabetes mellitus combination treatment rosiglitazone/metformin [Avandamet] has been announced

By  

Inpharma, Vol. 1, Iss. 1469, 2005-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

In Finland, repaglinide is dominant to nateglinide as combination therapy with metformin for the treatment of type 2 diabetes mellitus inadequately controlled with monotherapy

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 507, 2006-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Sitagliptin/Metformin Fixed-Dose Combination: In Patients with Type 2 Diabetes Mellitus

By Chwieduk Claudine M.  

Drugs, Vol. 71, Iss. 3, 2011-02 ,pp. : 349-361

Adis International

Access to resources Recommend Favorite